{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:52:55Z","timestamp":1793116375762,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The German government implemented the Digital Healthcare Act in order to bring Digital Therapeutics into standard medical care. This is one of the first regulatory pathways to reimbursement for Digital Therapeutics (DTx). The Digital Therapeutic sinCephalea is intended to act as a prophylactic treatment of migraine by reducing the migraine days. For this, sinCephalea determines personalized nutritional recommendations using continuous glucose monitoring (CGM) data and enables the patients to follow a personalized low-glycemic nutrition. Migraine is a headache disorder with the highest socioeconomic burden. Emerging evidence shows that CGM-based personalized nutritional recommendations are of prophylactic use in episodic migraine. However, prospective data are yet missing to demonstrate clinical effectiveness. This study is designed to fill this gap.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients between 18 and 65 years of age with proven migraine and a minimal disease severity of 3 migraine days per month are included. After a 4-week baseline phase as a pre-study, patients are randomized to the DTx intervention or a waiting-list control. The objective of the study is to show differences between the intervention and control groups regarding the change of migraine symptoms and of effects of migraine on daily life.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>To our knowledge, this is the first systematic clinical trial with a fully digital program to enable patients with migraine to follow a personalized low-glycemic nutrition in order to reduce their number of migraine days and the migraine-induced impact on daily life. Designing a clinical study using a digital intervention includes some obstacles, which are addressed in this study approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>German Registry of Clinical Studies (Deutsches Register Klinischer Studien) DRKS-ID DRKS00024657. Registered on March 8, 2021.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-022-06933-2","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:08:56Z","timestamp":1670803736000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy of the Digital Therapeutic sinCephalea in the prophylaxis of migraine in patients with episodic migraine: study protocol for a digital, randomized, open-label, standard treatment controlled trial"],"prefix":"10.1186","volume":"23","author":[{"given":"Torsten","family":"Schr\u00f6der","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna C. B.","family":"Brudermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianna","family":"K\u00fchn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Sina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diamant","family":"Tha\u00e7i","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Nitschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inke R.","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,12]]},"reference":[{"key":"6933_CR1","unstructured":"Driving the digital transformation of Germany\u2019s healthcare system for the good of patients [Internet]. [cited 2022 Feb 23]. Available from: https:\/\/www.bundesgesundheitsministerium.de\/en\/digital-healthcare-act.html"},{"key":"6933_CR2","unstructured":"European Data Protection Supervisor. Digital Therapeutics (DTx) [Internet]. [cited 2022 Feb 23]. Available from: https:\/\/edps.europa.eu\/press-publications\/publications\/techsonar\/digital-therapeutics-dtx_de"},{"key":"6933_CR3","unstructured":"Digital Therapeutics Alliance. DTx Product Categories - Fact Sheet [Internet]. [cited 2022 Feb 23]. Available from: https:\/\/dtxalliance.org\/wp-content\/uploads\/2021\/01\/DTA_FS_DTx-Product-Categories_010521.pdf"},{"key":"6933_CR4","unstructured":"Perfood GmbH. sinCephalea - product page [Internet]. [cited 2022 Feb 23]. Available from: https:\/\/sincephalea.de"},{"key":"6933_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1129-2377-14-1","volume":"14","author":"TJ Steiner","year":"2013","unstructured":"Steiner TJ, Stovner LJ, Birbeck GL. Migraine: the seventh disabler. J Headache Pain. 2013;14:1.","journal-title":"J Headache Pain"},{"key":"6933_CR6","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/S0140-6736(20)32342-4","volume":"397","author":"M Ashina","year":"2021","unstructured":"Ashina M, Buse DC, Ashina H, Pozo-Rosich P, Peres MFP, Lee MJ, et al. Migraine: integrated approaches to clinical management and emerging treatments. Lancet. 2021;397:1505\u201318.","journal-title":"Lancet."},{"key":"6933_CR7","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1055\/s-0038-1646946","volume":"38","author":"D Saylor","year":"2018","unstructured":"Saylor D, Steiner TJ. The global burden of headache. Semin Neurol. 2018;38:182\u201390.","journal-title":"Semin Neurol"},{"key":"6933_CR8","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/S1474-4422(18)30322-3","volume":"17","author":"GBD 2016 Headache Collaborators","year":"2018","unstructured":"GBD 2016 Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2018;17:954\u201376.","journal-title":"Lancet Neurol"},{"key":"6933_CR9","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/head.13275","volume":"58","author":"M Bonafede","year":"2018","unstructured":"Bonafede M, Sapra S, Shah N, Tepper S, Cappell K, Desai P. Direct and indirect healthcare resource utilization and costs among migraine patients in the United States. Headache. 2018;58:700\u201314.","journal-title":"Headache."},{"key":"6933_CR10","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s10194-019-1034-8","volume":"20","author":"C Ziegeler","year":"2019","unstructured":"Ziegeler C, Brauns G, J\u00fcrgens TP, May A. Shortcomings and missed potentials in the management of migraine patients - experiences from a specialized tertiary care center. J Headache Pain. 2019;20:86.","journal-title":"J Headache Pain"},{"key":"6933_CR11","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1177\/0333102416678382","volume":"37","author":"Z Hepp","year":"2017","unstructured":"Hepp Z, Dodick DW, Varon SF, Chia J, Matthew N, Gillard P, et al. Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: a retrospective claims analysis. Cephalalgia. 2017;37:470\u201385.","journal-title":"Cephalalgia."},{"key":"6933_CR12","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1111\/head.13157","volume":"57","author":"JM Woolley","year":"2017","unstructured":"Woolley JM, Bonafede MM, Maiese BA, Lenz RA. Migraine prophylaxis and acute treatment patterns among commercially insured patients in the United States. Headache. 2017;57:1399\u2013408.","journal-title":"Headache."},{"key":"6933_CR13","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1468-2982.2007.01303.x","volume":"27","author":"L Kelman","year":"2007","unstructured":"Kelman L. The triggers or precipitants of the acute migraine attack. Cephalalgia. 2007;27:394\u2013402.","journal-title":"Cephalalgia."},{"key":"6933_CR14","doi-asserted-by":"crossref","unstructured":"Evcili G. Early and long period follow-up results of low-glycemic index diet for migraine prophylaxis. Agri. 2018; [cited 2020 Nov 3]; Available from: http:\/\/www.agridergisi.com\/jvi.aspx?pdir=agri&plng=eng&un=AGRI-62443.","DOI":"10.5505\/agri.2017.62443"},{"key":"6933_CR15","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/s41591-020-0934-0","volume":"26","author":"SE Berry","year":"2020","unstructured":"Berry SE, Valdes AM, Drew DA, Asnicar F, Mazidi M, Wolf J, et al. Human postprandial responses to food and potential for precision nutrition. Nat Med. 2020;26:964\u201373.","journal-title":"Nat Med"},{"key":"6933_CR16","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.cmet.2017.05.002","volume":"25","author":"T Korem","year":"2017","unstructured":"Korem T, Zeevi D, Zmora N, Weissbrod O, Bar N, Lotan-Pompan M, et al. Bread affects clinical parameters and induces gut microbiome-associated personal glycemic responses. Cell Metab. 2017;25:1243\u20131253.e5 Elsevier Inc.","journal-title":"Cell Metab"},{"key":"6933_CR17","doi-asserted-by":"publisher","first-page":"e188102","DOI":"10.1001\/jamanetworkopen.2018.8102","volume":"2","author":"H Mendes-Soares","year":"2019","unstructured":"Mendes-Soares H, Raveh-Sadka T, Azulay S, Edens K, Ben-Shlomo Y, Cohen Y, et al. Assessment of a personalized approach to predicting postprandial glycemic responses to food among individuals without diabetes. JAMA Netw Open. 2019;2:e188102.","journal-title":"JAMA Netw Open"},{"key":"6933_CR18","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.cell.2015.11.001","volume":"163","author":"D Zeevi","year":"2015","unstructured":"Zeevi D, Korem T, Zmora N, Israeli D, Rothschild D, Weinberger A, et al. Personalized nutrition by prediction of glycemic responses. Cell. 2015;163:1079\u201394.","journal-title":"Cell"},{"key":"6933_CR19","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3945\/ajcn.115.129049","volume":"104","author":"on behalf of the Food4Me Study","year":"2016","unstructured":"on behalf of the Food4Me Study. Effect of an internet-based, personalized nutrition randomized trial on dietary changes associated with the Mediterranean diet: the Food4Me study. Am J Clin Nutr. 2016;104:288\u201397.","journal-title":"Am J Clin Nutr"},{"key":"6933_CR20","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.3390\/jcm11041117","volume":"11","author":"T Schr\u00f6der","year":"2022","unstructured":"Schr\u00f6der T, K\u00fchn G, Kordowski A, Jahromi SR, Gendolla A, Evers S, et al. A digital health application allowing a personalized low-glycemic nutrition for the prophylaxis of migraine: proof-of-concept data from a retrospective cohort study. J Clin Med. 2022;11:1117 Multidisciplinary Digital Publishing Institute.","journal-title":"J Clin Med"},{"key":"6933_CR21","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1177\/0333102420941839","volume":"40","author":"H-C Diener","year":"2020","unstructured":"Diener H-C, Tassorelli C, Dodick DW, Silberstein SD, Lipton RB, Ashina M, et al. Guidelines of the international headache society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults. Cephalalgia. 2020;40:1026\u201344.","journal-title":"Cephalalgia."},{"key":"6933_CR22","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1177\/0333102421989247","volume":"41","author":"HC Diener","year":"2021","unstructured":"Diener HC, Ashina M, Durand-Zaleski I, Kurth T, Lant\u00e9ri-Minet M, Lipton RB, et al. Health technology assessment for the acute and preventive treatment of migraine: a position statement of the international headache society. Cephalalgia. 2021;41:279\u201393.","journal-title":"Cephalalgia."},{"key":"6933_CR23","doi-asserted-by":"publisher","first-page":"e7586","DOI":"10.1136\/bmj.e7586","volume":"346","author":"A-W Chan","year":"2013","unstructured":"Chan A-W, Tetzlaff JM, G\u00f8tzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586 British Medical Journal Publishing Group.","journal-title":"BMJ"},{"key":"6933_CR24","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1001\/jama.293.17.2118","volume":"293","author":"K Linde","year":"2005","unstructured":"Linde K, Streng A, J\u00fcrgens S, Hoppe A, Brinkhaus B, Witt C, et al. Acupuncture for patients with migraine: a randomized controlled trial. JAMA. 2005;293:2118.","journal-title":"JAMA."},{"key":"6933_CR25","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1111\/j.1468-2982.2008.01640.x","volume":"28","author":"S Jena","year":"2008","unstructured":"Jena S, Witt CM, Brinkhaus B, Wegscheider K, Willich SN. Acupuncture in patients with headache. Cephalalgia. 2008;28:969\u201379.","journal-title":"Cephalalgia."},{"key":"6933_CR26","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1136\/bmj.38029.421863.EB","volume":"328","author":"AJ Vickers","year":"2004","unstructured":"Vickers AJ, Rees RW, Zollman CE, McCarney R, Smith CM, Ellis N, et al. Acupuncture for chronic headache in primary care: large, pragmatic, randomised trial. BMJ. 2004;328:744.","journal-title":"BMJ."},{"key":"6933_CR27","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/S1474-4422(06)70382-9","volume":"5","author":"H-C Diener","year":"2006","unstructured":"Diener H-C, Kronfeld K, Boewing G, Lungenhausen M, Maier C, Molsberger A, et al. Efficacy of acupuncture for the prophylaxis of migraine: a multicentre randomised controlled clinical trial. Lancet Neurol. 2006;5:310\u20136.","journal-title":"Lancet Neurol"},{"key":"6933_CR28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1129-2377-15-69","volume":"15","author":"AE Bunner","year":"2014","unstructured":"Bunner AE, Agarwal U, Gonzales JF, Valente F, Barnard ND. Nutrition intervention for migraine: a randomized crossover trial. J Headache Pain. 2014;15:69.","journal-title":"J Headache Pain"},{"key":"6933_CR29","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1055\/s-0030-1269928","volume":"32","author":"S Darabaneanu","year":"2011","unstructured":"Darabaneanu S, Overath CH, Rubin D, Luthje S, Sye W, Niederberger U, et al. Aerobic exercise as a therapy option for migraine: a pilot study. Int J Sports Med. 2011;32:455\u201360.","journal-title":"Int J Sports Med"},{"key":"6933_CR30","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1111\/sms.13023","volume":"28","author":"H Hanssen","year":"2018","unstructured":"Hanssen H, Minghetti A, Magon S, Rossmeissl A, Rasenack M, Papadopoulou A, et al. Effects of different endurance exercise modalities on migraine days and cerebrovascular health in episodic migraineurs: a randomized controlled trial. Scand J Med Sci Sports. 2018;28:1103\u201312.","journal-title":"Scand J Med Sci Sports"},{"key":"6933_CR31","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1177\/0333102417752119","volume":"38","author":"LS Kr\u00f8ll","year":"2018","unstructured":"Kr\u00f8ll LS, Hammarlund CS, Linde M, Gard G, Jensen RH. The effects of aerobic exercise for persons with migraine and co-existing tension-type headache and neck pain. A randomized, controlled, clinical trial. Cephalalgia. 2018;38:1805\u201316.","journal-title":"Cephalalgia."},{"key":"6933_CR32","volume-title":"nQuery advisor (version 4.0)","author":"JD Elashoff","year":"2000","unstructured":"Elashoff JD, Dixon JW, Crede MK. nQuery advisor (version 4.0). Saugus: Statistical Solutions; 2000. Available from: https:\/\/www.statsols.com"},{"key":"6933_CR33","volume-title":"Migraine disability assessment (MIDAS) questionnaire","author":"Caremark Inc","year":"1999","unstructured":"Caremark Inc. Migraine disability assessment (MIDAS) questionnaire; 1999. [cited 2021 Jun 1]. Available from: https:\/\/eprovide.mapi-trust.org\/instruments\/migraine-disability-assessment"},{"key":"6933_CR34","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1212\/WNL.53.5.988","volume":"53","author":"WF Stewart","year":"1999","unstructured":"Stewart WF, Lipton RB, Whyte J, Dowson A, Kolodner K, Liberman JN, et al. An international study to assess reliability of the migraine disability assessment (MIDAS) score. Neurology. 1999;53:988.","journal-title":"Neurology."},{"key":"6933_CR35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0304-3959(00)00305-5","volume":"88","author":"WF Stewart","year":"2000","unstructured":"Stewart WF, Lipton RB, Kolodner KB, Sawyer J, Lee C, Liberman JN. Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers. Pain. 2000;88:41\u201352.","journal-title":"Pain."},{"key":"6933_CR36","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.jclinepi.2005.05.010","volume":"59","author":"RR Coeytaux","year":"2006","unstructured":"Coeytaux RR, Kaufman JS, Chao R, Mann JD, Devellis RF. Four methods of estimating the minimal important difference score were compared to establish a clinically significant change in headache impact test. J Clin Epidemiol. 2006;59:374\u201380.","journal-title":"J Clin Epidemiol"},{"key":"6933_CR37","unstructured":"QualityMetric Inc. HIT-6TM - headache impact TestTM. Headache Impact TestTM. 2003; [cited 2021 Jun 1]. Available from: https:\/\/eprovide.mapi-trust.org\/instruments\/headache-impact-test."},{"key":"6933_CR38","volume-title":"EuroQoL-5 dimension questionnaire","author":"EuroQol Research Foundation","year":"2021","unstructured":"EuroQol Research Foundation. EuroQoL-5 dimension questionnaire; 2021. [cited 2021 Jun 7]. Available from: https:\/\/euroqol.org\/"},{"key":"6933_CR39","volume-title":"Patient global impression scale (PGI)","author":"National Institute of Mental Health (NIMH)","year":"1976","unstructured":"National Institute of Mental Health (NIMH). Patient global impression scale (PGI); 1976. [cited 2021 Jun 7]. Available from: https:\/\/eprovide.mapi-trust.org\/instruments\/patient-global-impressions-scale-change-improvement-severity"},{"key":"6933_CR40","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.psychres.2012.03.033","volume":"200","author":"S Jaeger","year":"2012","unstructured":"Jaeger S, Pfiffner C, Weiser P, Kilian R, Becker T, L\u00e4ngle G, et al. Adherence styles of schizophrenia patients identified by a latent class analysis of the medication adherence rating scale (MARS): a six-month follow-up study. Psychiatry Res. 2012;200:83\u20138.","journal-title":"Psychiatry Res"},{"key":"6933_CR41","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0920-9964(99)00130-9","volume":"42","author":"K Thompson","year":"2000","unstructured":"Thompson K, Kulkarni J, Sergejew AA. Reliability and validity of a new medication adherence rating scale (MARS) for the psychoses. Schizophr Res. 2000;42:241\u20137.","journal-title":"Schizophr Res"},{"key":"6933_CR42","first-page":"65","volume":"6","author":"S Holm","year":"1979","unstructured":"Holm S. A simple sequentially Rejective multiple test procedure. Scand J Stat. 1979;6:65\u201370 Board of the Foundation of the Scandinavian Journal of Statistics, Wiley.","journal-title":"Scand J Stat"},{"key":"6933_CR43","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1080\/10543406.2013.834911","volume":"23","author":"JR Carpenter","year":"2013","unstructured":"Carpenter JR, Roger JH, Kenward MG. Analysis of longitudinal trials with protocol deviation: a framework for relevant, accessible assumptions, and inference via multiple imputation. J Biopharm Stat. 2013;23:1352\u201371.","journal-title":"J Biopharm Stat"},{"key":"6933_CR44","doi-asserted-by":"crossref","first-page":"i","DOI":"10.1002\/9780470316696.fmatter","volume-title":"Multiple imputation for nonresponse in surveys. Multiple imputation for nonresponse in surveys","author":"Rubin","year":"1987","unstructured":"Rubin. Multiple imputation for nonresponse in surveys. Multiple imputation for nonresponse in surveys: Wiley; 1987. p. i\u2013xxix. [cited 2021 Jun 1]. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1002\/9780470316696.fmatter"},{"key":"6933_CR45","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/bimj.202000196","volume":"63","author":"JR Carpenter","year":"2021","unstructured":"Carpenter JR, Smuk M. Missing data: a statistical framework for practice. Biom J. 2021;63:915\u201347.","journal-title":"Biom J"},{"key":"6933_CR46","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s13063-017-1960-1","volume":"18","author":"C Giosan","year":"2017","unstructured":"Giosan C, Cobeanu O, Mogoa\u015fe C, Szentagotai A, Mure\u015fan V, Boian R. Reducing depressive symptomatology with a smartphone app: study protocol for a randomized, placebo-controlled trial. Trials. 2017;18:215.","journal-title":"Trials."},{"key":"6933_CR47","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jad.2017.04.046","volume":"218","author":"J Firth","year":"2017","unstructured":"Firth J, Torous J, Nicholas J, Carney R, Rosenbaum S, Sarris J. Can smartphone mental health interventions reduce symptoms of anxiety? A meta-analysis of randomized controlled trials. J Affect Disord. 2017;218:15\u201322.","journal-title":"J Affect Disord"},{"key":"6933_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41746-018-0021-9","volume":"1","author":"O Byambasuren","year":"2018","unstructured":"Byambasuren O, Sanders S, Beller E, Glasziou P. Prescribable mHealth apps identified from an overview of systematic reviews. NPJ Digital Med. 2018;1:1\u201312 Nature Publishing Group.","journal-title":"NPJ Digital Med"},{"key":"6933_CR49","first-page":"218","volume":"85","author":"JP Klein","year":"2016","unstructured":"Klein JP, Berger T, Schr\u00f6der J, Sp\u00e4th C, Meyer B, Caspar F, et al. Effects of a psychological internet intervention in the treatment of mild to moderate depressive symptoms: results of the EVIDENT study, a randomized controlled trial. PPS. 2016;85:218\u201328 Karger Publishers.","journal-title":"PPS"},{"key":"6933_CR50","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1136\/jnnp-2017-317463","volume":"89","author":"J P\u00f6ttgen","year":"2018","unstructured":"P\u00f6ttgen J, Moss-Morris R, Wendebourg J-M, Feddersen L, Lau S, K\u00f6pke S, et al. Randomised controlled trial of a self-guided online fatigue intervention in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2018;89:970\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"6933_CR51","doi-asserted-by":"crossref","unstructured":"Twomey C, O\u2019Reilly G, B\u00fcltmann O, Meyer B. Effectiveness of a tailored, integrative internet intervention (deprexis) for depression: updated meta-analysis. PLoS One. 2020;15 [cited 2021 Apr 26]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6992171\/.","DOI":"10.1371\/journal.pone.0228100"},{"key":"6933_CR52","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1017\/S1352465818000486","volume":"47","author":"N Lorenz","year":"2019","unstructured":"Lorenz N, Heim E, Roetger A, Birrer E, Maercker A. Randomized controlled trial to test the efficacy of an unguided online intervention with automated feedback for the treatment of insomnia. Behav Cogn Psychother. 2019;47:287\u2013302.","journal-title":"Behav Cogn Psychother"},{"key":"6933_CR53","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1159\/000492396","volume":"2","author":"AB Cohen","year":"2018","unstructured":"Cohen AB, Mathews SC. The digital outcome measure. Digit Biomark. 2018;2:94\u2013105.","journal-title":"Digit Biomark"},{"key":"6933_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41746-020-0224-8","volume":"3","author":"A Pratap","year":"2020","unstructured":"Pratap A, Neto EC, Snyder P, Stepnowsky C, Elhadad N, Grant D, et al. Indicators of retention in remote digital health studies: a cross-study evaluation of 100,000 participants. NPJ Digit Med. 2020;3:1\u201310 Nature Publishing Group.","journal-title":"NPJ Digit Med"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06933-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-022-06933-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06933-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T17:14:34Z","timestamp":1671124474000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-022-06933-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,12]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["6933"],"URL":"https:\/\/doi.org\/10.1186\/s13063-022-06933-2","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,12]]},"assertion":[{"value":"3 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The trial protocol is in accordance with the principles of the Declaration of Helsinki and has been approved by the ethics committee of the University Hospital L\u00fcbeck on 19 January 2021 (20-285). This trial was registered at the German Registry of Clinical Studies (Deutsches Register Klinischer Studien), DRKS-ID: DRKS00024657, registered on March 8, 2021. Each participant will be informed regarding the study protocol, and written informed consent will be obtained from each participant. The study site led by the principal investigator is responsible for collecting the informed consent. This is independently monitored by the ZKS.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"TS and GK are both employed at Perfood GmbH. TS and CS are co-founders of Perfood GmbH and minority shareholders. D.T.: consulting fees from Perfood; research support\/principal investigator (clinical trials): AbbVie, Almirall, Amgen, Biogen Idec, Boehringer Ingelheim, Dermira, Eli Lilly, Galderma, GSK, Janssen-Cilag, Leo-Pharma, Novartis, Pfizer, Regeneron, Roche, Sandoz-Hexal, Sanofi, and UCB; consultant: AbbVie, Almirall, Amgen, Dignity, Galapagos, Leo Pharma, Maruho, Mitsubishi, Novartis, Sanofi, Pfizer, Regeneron, Target-Solution, and UCB ; lectures: AbbVie, Almirall, Amgen, Janssen, Leo Pharma, MSD, Novartis, Pfizer, Roche-Posay, Sandoz-Hexal, Sanofi, and UCB; scientific advisory board: AbbVie, Boehringer Ingelheim, Eli Lilly, Galapagos, Janssen-Cilag, Leo Pharma, Morphosis, Novartis, Pfizer, Regeneron, Sanofi, and UCB.The views presented in this manuscript are those of the authors and not necessarily those of Perfood GmbH. Good publication practices were followed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"997"}}